Literature DB >> 31027666

Diagnosis and Management of Hepatitis B and C.

Michelle Pardee1.   

Abstract

Hepatitis B and C are complex and dynamic viral infections. An infected individual spreads the viruses to an uninfected individual in contaminated blood and body fluids. Acute hepatitis B and C infections may or may not produce mild symptoms and spontaneously resolve. Some individuals will progress to chronic hepatitis B and C, which can lead to liver fibrosis, cirrhosis, hepatocellular carcinoma, and possibly death. Choosing medications available to treat chronic hepatitis B and C is based on individual serology results, including genotype and level of liver damage. Treatment has been successful in inducing remission and complete recovery in many individuals.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic hepatitis B; Cirrhosis; Hepatitis B; Hepatitis C; Liver disease

Mesh:

Substances:

Year:  2019        PMID: 31027666     DOI: 10.1016/j.cnur.2019.02.004

Source DB:  PubMed          Journal:  Nurs Clin North Am        ISSN: 0029-6465            Impact factor:   1.208


  4 in total

1.  Associations between polymorphisms in IL-10 gene and the risk of viral hepatitis: a meta-analysis.

Authors:  Yuanyuan Zhang; Lisha Chen; Huixin Chen
Journal:  Gut Pathog       Date:  2020-07-28       Impact factor: 4.181

2.  Relationship of genetic polymorphisms in CTLA-4 and IL-18 with viral hepatitis: evidence from a meta-analysis.

Authors:  Yang Yu; Jie Qu; Chen Zhou; Guangqiang You
Journal:  Epidemiol Infect       Date:  2019-12-05       Impact factor: 2.451

Review 3.  Overview of the microbiota in the gut-liver axis in viral B and C hepatitis.

Authors:  Maria Adriana Neag; Andrei Otto Mitre; Adrian Catinean; Anca Dana Buzoianu
Journal:  World J Gastroenterol       Date:  2021-11-21       Impact factor: 5.742

4.  Kashmiri refugees at the verge of hepatitis B and C epidemic in the State of Azad Jammu and Kashmir, Pakistan.

Authors:  Syed Ayaz Kazmi; Abdul Rauf; Farheen Shafique; Noreen Asim; Nuzhat Shafi; Mahreen Ul Hassan
Journal:  Rev Saude Publica       Date:  2022-05-06       Impact factor: 2.772

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.